

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hepatocyte apoptotic process (GO:0097284) | 7.58906839 |
| 2 | ear development (GO:0043583) | 5.02911051 |
| 3 | striated muscle atrophy (GO:0014891) | 4.94420124 |
| 4 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.80742822 |
| 5 | regulation of establishment of cell polarity (GO:2000114) | 4.77021466 |
| 6 | intestinal epithelial cell development (GO:0060576) | 4.59668759 |
| 7 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 4.46789724 |
| 8 | skeletal muscle adaptation (GO:0043501) | 4.41717677 |
| 9 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.32866094 |
| 10 | muscle atrophy (GO:0014889) | 4.31381633 |
| 11 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.92740894 |
| 12 | regulation of centriole replication (GO:0046599) | 3.87249832 |
| 13 | nuclear pore complex assembly (GO:0051292) | 3.71195224 |
| 14 | TOR signaling (GO:0031929) | 3.69559819 |
| 15 | nuclear pore organization (GO:0006999) | 3.68882552 |
| 16 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.66082088 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.65159021 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53652002 |
| 19 | negative regulation of organelle assembly (GO:1902116) | 3.48748511 |
| 20 | cellular response to interferon-alpha (GO:0035457) | 3.44289316 |
| 21 | pore complex assembly (GO:0046931) | 3.36524198 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.34961246 |
| 23 | embryonic eye morphogenesis (GO:0048048) | 3.34057413 |
| 24 | interferon-gamma secretion (GO:0072643) | 3.30278195 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 3.25914193 |
| 26 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.25579935 |
| 27 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.22986554 |
| 28 | COPI coating of Golgi vesicle (GO:0048205) | 3.14884716 |
| 29 | Golgi transport vesicle coating (GO:0048200) | 3.14884716 |
| 30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.14833163 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11930683 |
| 32 | ER overload response (GO:0006983) | 3.11757977 |
| 33 | regulation of interleukin-13 production (GO:0032656) | 3.11594226 |
| 34 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.05597206 |
| 35 | B cell mediated immunity (GO:0019724) | 3.04322000 |
| 36 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.01550781 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98605283 |
| 38 | positive regulation of translational initiation (GO:0045948) | 2.96239287 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 2.95508110 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.94956407 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.94956407 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.94956407 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 2.94956407 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 2.94956407 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 2.94956407 |
| 46 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.94305843 |
| 47 | T-helper cell differentiation (GO:0042093) | 2.94305843 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94218565 |
| 49 | trophectodermal cell differentiation (GO:0001829) | 2.92210590 |
| 50 | histone H3-K4 trimethylation (GO:0080182) | 2.91810911 |
| 51 | negative thymic T cell selection (GO:0045060) | 2.91436845 |
| 52 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91284148 |
| 53 | positive regulation of interferon-alpha production (GO:0032727) | 2.90132713 |
| 54 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.90058746 |
| 55 | regulation of interferon-alpha production (GO:0032647) | 2.86464220 |
| 56 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84427474 |
| 57 | mitotic metaphase plate congression (GO:0007080) | 2.84027114 |
| 58 | negative regulation of DNA repair (GO:0045738) | 2.83342532 |
| 59 | protein localization to kinetochore (GO:0034501) | 2.82556416 |
| 60 | negative T cell selection (GO:0043383) | 2.82060811 |
| 61 | regulation of water loss via skin (GO:0033561) | 2.81717688 |
| 62 | positive thymic T cell selection (GO:0045059) | 2.79627448 |
| 63 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.77840506 |
| 64 | mammary gland epithelial cell proliferation (GO:0033598) | 2.77696044 |
| 65 | COPII vesicle coating (GO:0048208) | 2.77422791 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 2.77187560 |
| 67 | positive regulation of interleukin-4 production (GO:0032753) | 2.75919327 |
| 68 | regulation of B cell differentiation (GO:0045577) | 2.75884891 |
| 69 | mitotic nuclear envelope disassembly (GO:0007077) | 2.75344618 |
| 70 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.73328230 |
| 71 | uterus development (GO:0060065) | 2.73313752 |
| 72 | embryonic process involved in female pregnancy (GO:0060136) | 2.70143364 |
| 73 | B cell homeostasis (GO:0001782) | 2.68297192 |
| 74 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.67143053 |
| 75 | oocyte development (GO:0048599) | 2.66067636 |
| 76 | cell-substrate adherens junction assembly (GO:0007045) | 2.65706928 |
| 77 | focal adhesion assembly (GO:0048041) | 2.65706928 |
| 78 | T cell lineage commitment (GO:0002360) | 2.65576624 |
| 79 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.65231322 |
| 80 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.65231322 |
| 81 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.63760199 |
| 82 | regulation of spindle organization (GO:0090224) | 2.63644007 |
| 83 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.63227143 |
| 84 | regulation of mitotic spindle organization (GO:0060236) | 2.62954258 |
| 85 | positive regulation of interferon-beta production (GO:0032728) | 2.62106065 |
| 86 | post-embryonic morphogenesis (GO:0009886) | 2.60032880 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 2.59986497 |
| 88 | maternal placenta development (GO:0001893) | 2.59531760 |
| 89 | * positive regulation of keratinocyte differentiation (GO:0045618) | 2.59011140 |
| 90 | protein localization to chromosome, centromeric region (GO:0071459) | 2.58862398 |
| 91 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.57654294 |
| 92 | natural killer cell mediated immunity (GO:0002228) | 2.57654294 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 2.56859540 |
| 94 | negative regulation of B cell proliferation (GO:0030889) | 2.56554496 |
| 95 | negative regulation of granulocyte differentiation (GO:0030853) | 2.56476534 |
| 96 | neutrophil activation involved in immune response (GO:0002283) | 2.55802193 |
| 97 | negative regulation of histone methylation (GO:0031061) | 2.54831968 |
| 98 | lymphoid progenitor cell differentiation (GO:0002320) | 2.54477411 |
| 99 | regulation of RNA export from nucleus (GO:0046831) | 2.51825733 |
| 100 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.51795422 |
| 101 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.51795422 |
| 102 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.51795422 |
| 103 | metaphase plate congression (GO:0051310) | 2.51396126 |
| 104 | activation of Rac GTPase activity (GO:0032863) | 2.51088615 |
| 105 | peptidyl-lysine trimethylation (GO:0018023) | 2.50842515 |
| 106 | nuclear envelope disassembly (GO:0051081) | 2.50410638 |
| 107 | membrane disassembly (GO:0030397) | 2.50410638 |
| 108 | determination of adult lifespan (GO:0008340) | 2.49189265 |
| 109 | protein K6-linked ubiquitination (GO:0085020) | 2.49094129 |
| 110 | pinocytosis (GO:0006907) | 2.48781924 |
| 111 | meiotic chromosome segregation (GO:0045132) | 2.48715300 |
| 112 | DNA replication checkpoint (GO:0000076) | 2.48349527 |
| 113 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.48031144 |
| 114 | positive regulation of chromosome segregation (GO:0051984) | 2.47415969 |
| 115 | thymic T cell selection (GO:0045061) | 2.47381407 |
| 116 | mitotic sister chromatid cohesion (GO:0007064) | 2.47180788 |
| 117 | desmosome organization (GO:0002934) | 2.47085284 |
| 118 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.45995292 |
| 119 | leukocyte aggregation (GO:0070486) | 2.45138347 |
| 120 | regulation of integrin activation (GO:0033623) | 2.44481782 |
| 121 | T cell differentiation involved in immune response (GO:0002292) | 2.44218829 |
| 122 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.44218829 |
| 123 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.44218829 |
| 124 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.43894149 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 2.42403373 |
| 126 | peptidyl-lysine dimethylation (GO:0018027) | 2.42176379 |
| 127 | establishment of chromosome localization (GO:0051303) | 2.41869614 |
| 128 | positive regulation of hormone metabolic process (GO:0032352) | 2.41732999 |
| 129 | response to interferon-alpha (GO:0035455) | 2.40735581 |
| 130 | cardiac right ventricle morphogenesis (GO:0003215) | 2.40559969 |
| 131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40545732 |
| 132 | peptidyl-lysine methylation (GO:0018022) | 2.40242945 |
| 133 | regulation of histone H3-K27 methylation (GO:0061085) | 2.40094117 |
| 134 | corticosteroid receptor signaling pathway (GO:0031958) | 2.39676185 |
| 135 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.38618583 |
| 136 | inner cell mass cell proliferation (GO:0001833) | 2.38263750 |
| 137 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.38240236 |
| 138 | regulation of gene silencing by miRNA (GO:0060964) | 2.38240236 |
| 139 | regulation of gene silencing by RNA (GO:0060966) | 2.38240236 |
| 140 | norepinephrine metabolic process (GO:0042415) | 2.38115199 |
| 141 | tolerance induction (GO:0002507) | 2.37904813 |
| 142 | cell proliferation involved in metanephros development (GO:0072203) | 2.37889090 |
| 143 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.37867143 |
| 144 | neutrophil activation (GO:0042119) | 2.37711195 |
| 145 | germinal center formation (GO:0002467) | 2.37485549 |
| 146 | activation of Rho GTPase activity (GO:0032862) | 2.37238251 |
| 147 | DNA replication initiation (GO:0006270) | 2.36226161 |
| 148 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.35605735 |
| 149 | regulation of antigen processing and presentation (GO:0002577) | 2.35394270 |
| 150 | response to muramyl dipeptide (GO:0032495) | 2.35388787 |
| 151 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.35379924 |
| 152 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.35379924 |
| 153 | chondrocyte development (GO:0002063) | 2.34795184 |
| 154 | interferon-gamma production (GO:0032609) | 2.34569339 |
| 155 | T cell selection (GO:0045058) | 2.34069857 |
| 156 | histone lysine demethylation (GO:0070076) | 2.33779705 |
| 157 | response to peptidoglycan (GO:0032494) | 2.33732598 |
| 158 | activation of Ras GTPase activity (GO:0032856) | 2.33701831 |
| 159 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.33627932 |
| 160 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.33356393 |
| 161 | histone H3-K4 methylation (GO:0051568) | 2.33039028 |
| 162 | negative regulation of cell size (GO:0045792) | 2.32893055 |
| 163 | regulation of centrosome duplication (GO:0010824) | 2.32692380 |
| 164 | regulation of protein polyubiquitination (GO:1902914) | 2.32641075 |
| 165 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32593356 |
| 166 | regulation of RIG-I signaling pathway (GO:0039535) | 2.31908125 |
| 167 | mitotic sister chromatid segregation (GO:0000070) | 2.29552274 |
| 168 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.29454226 |
| 169 | regulation of T cell tolerance induction (GO:0002664) | 2.28267624 |
| 170 | regulation of histone H3-K9 methylation (GO:0051570) | 2.28035151 |
| 171 | histone H3-K36 demethylation (GO:0070544) | 2.27722648 |
| 172 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.26979395 |
| 173 | regulation of chromatin silencing (GO:0031935) | 2.26782736 |
| 174 | mitotic chromosome condensation (GO:0007076) | 2.26372057 |
| 175 | telomere maintenance via recombination (GO:0000722) | 2.25927013 |
| 176 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.25579784 |
| 177 | regulation of response to interferon-gamma (GO:0060330) | 2.25503177 |
| 178 | histone H4-K12 acetylation (GO:0043983) | 2.25349307 |
| 179 | granulocyte activation (GO:0036230) | 2.24666994 |
| 180 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.24551424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.79684229 |
| 2 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.85093288 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.07436456 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.87521432 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.81214680 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45739706 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.45407268 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.32479501 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.32302696 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.28870591 |
| 11 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.19531874 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.02034488 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.93375492 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.69280852 |
| 15 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 2.62321344 |
| 16 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.62107159 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.56258629 |
| 18 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.43386944 |
| 19 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 2.41073107 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40369228 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.37146739 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.29483062 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.24145205 |
| 24 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 2.23153181 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16408872 |
| 26 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14028728 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13958364 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07899895 |
| 29 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06785332 |
| 30 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 2.01001726 |
| 31 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.97874303 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92952804 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87274774 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86454308 |
| 35 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.85817803 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85473495 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81775664 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77049009 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75739377 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69867117 |
| 41 | MYB_26560356_Chip-Seq_TH2_Human | 1.69413598 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69195535 |
| 43 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.68700320 |
| 44 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.68484168 |
| 45 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.68374446 |
| 46 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.68374446 |
| 47 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.68374446 |
| 48 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.67956016 |
| 49 | * MYB_26560356_Chip-Seq_TH1_Human | 1.67732344 |
| 50 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.67270314 |
| 51 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65129516 |
| 52 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.64972305 |
| 53 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61154737 |
| 54 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.61069543 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60004139 |
| 56 | * MAF_26560356_Chip-Seq_TH1_Human | 1.58195123 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56554644 |
| 58 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.54247492 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53971797 |
| 60 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.53875029 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51469324 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49862245 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.49113298 |
| 64 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.48992176 |
| 65 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48863487 |
| 66 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.47085072 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47048234 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44846058 |
| 69 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.44477237 |
| 70 | * TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.44196547 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43995825 |
| 72 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40496335 |
| 73 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40407948 |
| 74 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.35657146 |
| 75 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.34320742 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33639147 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33136223 |
| 78 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32685849 |
| 79 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32569313 |
| 80 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32463133 |
| 81 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31468745 |
| 82 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.30782363 |
| 83 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29670941 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.29623202 |
| 85 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28461833 |
| 86 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26671699 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25765690 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25531022 |
| 89 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25515756 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25515756 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23234949 |
| 92 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.22520998 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.22445129 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21834758 |
| 95 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21663378 |
| 96 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21135443 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20504916 |
| 98 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.20026150 |
| 99 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19874960 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19241566 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17932484 |
| 102 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17418066 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14620708 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13477722 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12674871 |
| 106 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.10859441 |
| 107 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10342267 |
| 108 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09713567 |
| 109 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09503617 |
| 110 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.09042643 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07885367 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07612264 |
| 113 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07519381 |
| 114 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07352867 |
| 115 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.07206050 |
| 116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06719544 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05379567 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04346777 |
| 119 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04114795 |
| 120 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02928590 |
| 121 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02503023 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 1.02163295 |
| 123 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01433452 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00175561 |
| 125 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99996806 |
| 126 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.99128689 |
| 127 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.98914740 |
| 128 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98830864 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98268315 |
| 130 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.97807216 |
| 131 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97206649 |
| 132 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97178825 |
| 133 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97171863 |
| 134 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.92562393 |
| 135 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92312907 |
| 136 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.91315591 |
| 137 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.90887638 |
| 138 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90283003 |
| 139 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.88919533 |
| 140 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.88112570 |
| 141 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87928144 |
| 142 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.87794324 |
| 143 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.87331366 |
| 144 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86749128 |
| 145 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.86386012 |
| 146 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85733931 |
| 147 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83278011 |
| 148 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.83182504 |
| 149 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.82653016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004381_abnormal_hair_follicle | 3.49901117 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 3.48620005 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.48233251 |
| 4 | MP0008057_abnormal_DNA_replication | 2.90847444 |
| 5 | MP0005451_abnormal_body_composition | 2.84855010 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.50227797 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.50202015 |
| 8 | MP0001800_abnormal_humoral_immune | 2.49512706 |
| 9 | MP0002796_impaired_skin_barrier | 2.48371541 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.47590167 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.45970571 |
| 12 | MP0000383_abnormal_hair_follicle | 2.45240405 |
| 13 | MP0005671_abnormal_response_to | 2.42885705 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.41354070 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.39391051 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.35996205 |
| 17 | MP0001790_abnormal_immune_system | 2.35109826 |
| 18 | MP0005387_immune_system_phenotype | 2.35109826 |
| 19 | MP0003077_abnormal_cell_cycle | 2.31622678 |
| 20 | MP0010678_abnormal_skin_adnexa | 2.25942273 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.25267325 |
| 22 | MP0000685_abnormal_immune_system | 2.25175706 |
| 23 | MP0003303_peritoneal_inflammation | 2.24583737 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.22080207 |
| 25 | MP0003436_decreased_susceptibility_to | 2.12292636 |
| 26 | MP0005000_abnormal_immune_tolerance | 2.09570002 |
| 27 | MP0010307_abnormal_tumor_latency | 2.08300823 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.08280500 |
| 29 | MP0005408_hypopigmentation | 2.03495158 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 2.02736075 |
| 31 | MP0002723_abnormal_immune_serum | 2.02040217 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.97432660 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.96291090 |
| 34 | MP0001819_abnormal_immune_cell | 1.95733745 |
| 35 | MP0004233_abnormal_muscle_weight | 1.95602599 |
| 36 | MP0002398_abnormal_bone_marrow | 1.94557147 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.89473862 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.88541054 |
| 39 | MP0008007_abnormal_cellular_replicative | 1.81558668 |
| 40 | MP0008058_abnormal_DNA_repair | 1.79415946 |
| 41 | MP0002419_abnormal_innate_immunity | 1.79238666 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.76515648 |
| 43 | MP0000716_abnormal_immune_system | 1.73953812 |
| 44 | MP0000427_abnormal_hair_cycle | 1.73167766 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.72772711 |
| 46 | MP0005025_abnormal_response_to | 1.70754730 |
| 47 | MP0004510_myositis | 1.69504205 |
| 48 | MP0002006_tumorigenesis | 1.67924817 |
| 49 | MP0002405_respiratory_system_inflammati | 1.66783996 |
| 50 | MP0002722_abnormal_immune_system | 1.65101448 |
| 51 | MP0004957_abnormal_blastocyst_morpholog | 1.64487716 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.62711656 |
| 53 | MP0005501_abnormal_skin_physiology | 1.62221326 |
| 54 | MP0006082_CNS_inflammation | 1.61843767 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.60128815 |
| 56 | MP0002098_abnormal_vibrissa_morphology | 1.56938814 |
| 57 | MP0009278_abnormal_bone_marrow | 1.55261750 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.54341183 |
| 59 | MP0009785_altered_susceptibility_to | 1.52224068 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 1.51446837 |
| 61 | MP0001545_abnormal_hematopoietic_system | 1.51446837 |
| 62 | MP0000490_abnormal_crypts_of | 1.50326481 |
| 63 | MP0001873_stomach_inflammation | 1.49958939 |
| 64 | MP0005310_abnormal_salivary_gland | 1.49157544 |
| 65 | MP0002429_abnormal_blood_cell | 1.48847768 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.43948898 |
| 67 | MP0000377_abnormal_hair_follicle | 1.43534601 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.35886143 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.35149097 |
| 70 | MP0002009_preneoplasia | 1.35012908 |
| 71 | MP0001853_heart_inflammation | 1.34742657 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.34390511 |
| 73 | MP0003448_altered_tumor_morphology | 1.33498563 |
| 74 | MP0005409_darkened_coat_color | 1.30709182 |
| 75 | * MP0000350_abnormal_cell_proliferation | 1.30322892 |
| 76 | MP0003828_pulmonary_edema | 1.25284533 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 1.25246441 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 1.24078045 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 1.22903250 |
| 80 | MP0003786_premature_aging | 1.20154812 |
| 81 | * MP0000627_abnormal_mammary_gland | 1.20011766 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.19321705 |
| 83 | MP0000371_diluted_coat_color | 1.18901171 |
| 84 | * MP0005076_abnormal_cell_differentiation | 1.18534468 |
| 85 | MP0001727_abnormal_embryo_implantation | 1.17282020 |
| 86 | MP0004947_skin_inflammation | 1.15522287 |
| 87 | MP0001348_abnormal_lacrimal_gland | 1.13839718 |
| 88 | MP0003724_increased_susceptibility_to | 1.13817926 |
| 89 | MP0000462_abnormal_digestive_system | 1.13733567 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 1.13565492 |
| 91 | MP0003566_abnormal_cell_adhesion | 1.12907043 |
| 92 | * MP0002019_abnormal_tumor_incidence | 1.12425364 |
| 93 | MP0001216_abnormal_epidermal_layer | 1.09840087 |
| 94 | MP0000015_abnormal_ear_pigmentation | 1.08562780 |
| 95 | MP0001730_embryonic_growth_arrest | 1.08515550 |
| 96 | MP0000858_altered_metastatic_potential | 1.06933076 |
| 97 | MP0005058_abnormal_lysosome_morphology | 1.06486522 |
| 98 | MP0003300_gastrointestinal_ulcer | 1.06464839 |
| 99 | MP0000465_gastrointestinal_hemorrhage | 1.05000891 |
| 100 | MP0005380_embryogenesis_phenotype | 1.04644521 |
| 101 | MP0001672_abnormal_embryogenesis/_devel | 1.04644521 |
| 102 | MP0001881_abnormal_mammary_gland | 1.03831979 |
| 103 | MP0009672_abnormal_birth_weight | 1.02379862 |
| 104 | MP0000470_abnormal_stomach_morphology | 0.98944021 |
| 105 | MP0000313_abnormal_cell_death | 0.98524044 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.96245442 |
| 107 | MP0003984_embryonic_growth_retardation | 0.95927305 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 0.95364265 |
| 109 | MP0008260_abnormal_autophagy | 0.94721797 |
| 110 | MP0001666_abnormal_nutrient_absorption | 0.93880748 |
| 111 | MP0002086_abnormal_extraembryonic_tissu | 0.93650802 |
| 112 | MP0008877_abnormal_DNA_methylation | 0.92782503 |
| 113 | MP0003941_abnormal_skin_development | 0.92676245 |
| 114 | MP0008995_early_reproductive_senescence | 0.92443346 |
| 115 | MP0005023_abnormal_wound_healing | 0.91851658 |
| 116 | MP0004883_abnormal_blood_vessel | 0.91639067 |
| 117 | MP0001533_abnormal_skeleton_physiology | 0.90480685 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88408815 |
| 119 | MP0002075_abnormal_coat/hair_pigmentati | 0.88132184 |
| 120 | MP0003787_abnormal_imprinting | 0.88017067 |
| 121 | MP0001186_pigmentation_phenotype | 0.87492286 |
| 122 | MP0003718_maternal_effect | 0.87123152 |
| 123 | MP0003123_paternal_imprinting | 0.85543760 |
| 124 | MP0002254_reproductive_system_inflammat | 0.84537099 |
| 125 | MP0003172_abnormal_lysosome_physiology | 0.84320915 |
| 126 | MP0009840_abnormal_foam_cell | 0.83707883 |
| 127 | MP0001915_intracranial_hemorrhage | 0.83178981 |
| 128 | MP0002933_joint_inflammation | 0.81370216 |
| 129 | MP0008932_abnormal_embryonic_tissue | 0.80586361 |
| 130 | MP0009703_decreased_birth_body | 0.79024834 |
| 131 | * MP0001697_abnormal_embryo_size | 0.78309636 |
| 132 | MP0008469_abnormal_protein_level | 0.77076832 |
| 133 | MP0009931_abnormal_skin_appearance | 0.76328841 |
| 134 | * MP0005621_abnormal_cell_physiology | 0.74558289 |
| 135 | MP0000767_abnormal_smooth_muscle | 0.73949542 |
| 136 | MP0005367_renal/urinary_system_phenotyp | 0.73176734 |
| 137 | MP0000516_abnormal_urinary_system | 0.73176734 |
| 138 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72205278 |
| 139 | MP0003091_abnormal_cell_migration | 0.71294665 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.71034379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | J-shaped sella turcica (HP:0002680) | 5.87962766 |
| 2 | Asymmetry of the thorax (HP:0001555) | 5.72110604 |
| 3 | Absent frontal sinuses (HP:0002688) | 5.20943599 |
| 4 | Micronodular cirrhosis (HP:0001413) | 4.50888694 |
| 5 | Microglossia (HP:0000171) | 4.17209824 |
| 6 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 4.09015531 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.03072119 |
| 8 | Abnormality of the fingertips (HP:0001211) | 3.92213312 |
| 9 | Deformed sella turcica (HP:0002681) | 3.88651720 |
| 10 | Papillary thyroid carcinoma (HP:0002895) | 3.86627643 |
| 11 | Septate vagina (HP:0001153) | 3.85456418 |
| 12 | Chromsome breakage (HP:0040012) | 3.68712945 |
| 13 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.68083693 |
| 14 | Curly hair (HP:0002212) | 3.56939305 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.50185365 |
| 16 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.48759674 |
| 17 | Abnormality of the frontal sinuses (HP:0002687) | 3.46111685 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.36500482 |
| 19 | Macroorchidism (HP:0000053) | 3.17012945 |
| 20 | Thyroid carcinoma (HP:0002890) | 3.16826380 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.14737478 |
| 22 | Breast carcinoma (HP:0003002) | 3.11915325 |
| 23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.11269733 |
| 24 | Spinal cord lesions (HP:0100561) | 3.09521175 |
| 25 | Syringomyelia (HP:0003396) | 3.09521175 |
| 26 | Testicular neoplasm (HP:0010788) | 3.08339670 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.07968062 |
| 28 | Agnosia (HP:0010524) | 3.03560035 |
| 29 | Recurrent viral infections (HP:0004429) | 3.03197097 |
| 30 | Germ cell neoplasia (HP:0100728) | 3.00326878 |
| 31 | Pustule (HP:0200039) | 2.96706281 |
| 32 | Myositis (HP:0100614) | 2.93304477 |
| 33 | Birth length less than 3rd percentile (HP:0003561) | 2.92709637 |
| 34 | Cutaneous melanoma (HP:0012056) | 2.89040520 |
| 35 | Deep philtrum (HP:0002002) | 2.89035422 |
| 36 | Esophageal varix (HP:0002040) | 2.85036794 |
| 37 | Abnormality of the sella turcica (HP:0002679) | 2.83469108 |
| 38 | Optic neuritis (HP:0100653) | 2.81153449 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.81153449 |
| 40 | Intestinal fistula (HP:0100819) | 2.80332344 |
| 41 | Prostate neoplasm (HP:0100787) | 2.79155957 |
| 42 | IgM deficiency (HP:0002850) | 2.75767521 |
| 43 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.72196801 |
| 44 | Ectopic kidney (HP:0000086) | 2.71379477 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.68750858 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.68435397 |
| 47 | Abnormality of chromosome stability (HP:0003220) | 2.58719372 |
| 48 | Hyperacusis (HP:0010780) | 2.55360744 |
| 49 | Orchitis (HP:0100796) | 2.55283621 |
| 50 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.52945395 |
| 51 | Amaurosis fugax (HP:0100576) | 2.52607072 |
| 52 | Impulsivity (HP:0100710) | 2.52072184 |
| 53 | Embryonal renal neoplasm (HP:0011794) | 2.51669204 |
| 54 | Flat acetabular roof (HP:0003180) | 2.46813629 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.44634606 |
| 56 | Clubbing of toes (HP:0100760) | 2.43650701 |
| 57 | Leiomyosarcoma (HP:0100243) | 2.42483009 |
| 58 | Uterine leiomyosarcoma (HP:0002891) | 2.42483009 |
| 59 | Meckel diverticulum (HP:0002245) | 2.41743220 |
| 60 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40548015 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40548015 |
| 62 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.38763803 |
| 63 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.37387798 |
| 64 | Myelodysplasia (HP:0002863) | 2.36812996 |
| 65 | Cellulitis (HP:0100658) | 2.35161989 |
| 66 | Gastrointestinal stroma tumor (HP:0100723) | 2.33434571 |
| 67 | Chronic otitis media (HP:0000389) | 2.32505466 |
| 68 | Panhypogammaglobulinemia (HP:0003139) | 2.31375256 |
| 69 | Abnormality of the ileum (HP:0001549) | 2.30639524 |
| 70 | Meningitis (HP:0001287) | 2.30602661 |
| 71 | Leukopenia (HP:0001882) | 2.30360711 |
| 72 | Bladder carcinoma (HP:0002862) | 2.29629597 |
| 73 | Bladder neoplasm (HP:0009725) | 2.29629597 |
| 74 | Stomatitis (HP:0010280) | 2.29590502 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.27792265 |
| 76 | IgA deficiency (HP:0002720) | 2.27771716 |
| 77 | Eosinophilia (HP:0001880) | 2.27288353 |
| 78 | Termporal pattern (HP:0011008) | 2.26600724 |
| 79 | Insidious onset (HP:0003587) | 2.26600724 |
| 80 | Recurrent skin infections (HP:0001581) | 2.24805769 |
| 81 | Abnormality of the preputium (HP:0100587) | 2.22985936 |
| 82 | Leukocytosis (HP:0001974) | 2.21610972 |
| 83 | Acute myeloid leukemia (HP:0004808) | 2.20931218 |
| 84 | Abnormality of macrophages (HP:0004311) | 2.20359515 |
| 85 | Hypopigmentation of the fundus (HP:0007894) | 2.19351058 |
| 86 | Arterial thrombosis (HP:0004420) | 2.18765132 |
| 87 | Obstructive lung disease (HP:0006536) | 2.18748556 |
| 88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18748556 |
| 89 | Vasculitis (HP:0002633) | 2.18213350 |
| 90 | Lymphoma (HP:0002665) | 2.18209125 |
| 91 | Viral hepatitis (HP:0006562) | 2.17258823 |
| 92 | T lymphocytopenia (HP:0005403) | 2.16705221 |
| 93 | Heterotopia (HP:0002282) | 2.16467007 |
| 94 | Sparse lateral eyebrow (HP:0005338) | 2.15648518 |
| 95 | Neoplasm of the thyroid gland (HP:0100031) | 2.15641973 |
| 96 | Subacute progressive viral hepatitis (HP:0006572) | 2.15463328 |
| 97 | Menstrual irregularities (HP:0000858) | 2.14725551 |
| 98 | Hematochezia (HP:0002573) | 2.13280964 |
| 99 | Colitis (HP:0002583) | 2.13037170 |
| 100 | Periodontitis (HP:0000704) | 2.12646186 |
| 101 | Abdominal distention (HP:0003270) | 2.11501386 |
| 102 | Abnormality of T cells (HP:0002843) | 2.11441461 |
| 103 | Recurrent bronchitis (HP:0002837) | 2.10567060 |
| 104 | Coarse hair (HP:0002208) | 2.08622040 |
| 105 | Concave nail (HP:0001598) | 2.07713839 |
| 106 | Rectal fistula (HP:0100590) | 2.05297475 |
| 107 | Rectovaginal fistula (HP:0000143) | 2.05297475 |
| 108 | Medulloblastoma (HP:0002885) | 2.04956491 |
| 109 | Abnormality of the prostate (HP:0008775) | 2.04423256 |
| 110 | Granulocytopenia (HP:0001913) | 2.04036916 |
| 111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03814216 |
| 112 | Renal cell carcinoma (HP:0005584) | 2.03524924 |
| 113 | IgG deficiency (HP:0004315) | 2.02998583 |
| 114 | Gingivitis (HP:0000230) | 2.00666448 |
| 115 | Anal stenosis (HP:0002025) | 1.99769454 |
| 116 | Systemic lupus erythematosus (HP:0002725) | 1.99436744 |
| 117 | Urethral obstruction (HP:0000796) | 1.99063439 |
| 118 | Bone marrow hypocellularity (HP:0005528) | 1.98936125 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.98919205 |
| 120 | Inflammation of the large intestine (HP:0002037) | 1.96718591 |
| 121 | Breast hypoplasia (HP:0003187) | 1.95735247 |
| 122 | Pulmonary infiltrates (HP:0002113) | 1.94863619 |
| 123 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.94168130 |
| 124 | Gastrointestinal carcinoma (HP:0002672) | 1.94168130 |
| 125 | Carpal bone hypoplasia (HP:0001498) | 1.93423742 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 1.93235395 |
| 127 | Prominent nose (HP:0000448) | 1.92249437 |
| 128 | Abnormality of eosinophils (HP:0001879) | 1.90331173 |
| 129 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89781562 |
| 130 | Spontaneous hematomas (HP:0007420) | 1.89780486 |
| 131 | Verrucae (HP:0200043) | 1.88624572 |
| 132 | Papilloma (HP:0012740) | 1.88624572 |
| 133 | Basal cell carcinoma (HP:0002671) | 1.87896928 |
| 134 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87763578 |
| 135 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87763578 |
| 136 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87763578 |
| 137 | Ependymoma (HP:0002888) | 1.87432100 |
| 138 | Patellar aplasia (HP:0006443) | 1.87147039 |
| 139 | Thyroiditis (HP:0100646) | 1.86946097 |
| 140 | Lymphopenia (HP:0001888) | 1.86932331 |
| 141 | Chronic diarrhea (HP:0002028) | 1.86130895 |
| 142 | Abnormality of the gastric mucosa (HP:0004295) | 1.85993836 |
| 143 | Enlarged penis (HP:0000040) | 1.85471747 |
| 144 | Keratoconjunctivitis sicca (HP:0001097) | 1.85042185 |
| 145 | Depressed nasal tip (HP:0000437) | 1.85023262 |
| 146 | Absent radius (HP:0003974) | 1.83923550 |
| 147 | Abnormality of DNA repair (HP:0003254) | 1.83912019 |
| 148 | Encephalitis (HP:0002383) | 1.82131392 |
| 149 | Osteomyelitis (HP:0002754) | 1.81828784 |
| 150 | Broad face (HP:0000283) | 1.81594199 |
| 151 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.80963466 |
| 152 | Fatigue (HP:0012378) | 1.80810231 |
| 153 | Hepatitis (HP:0012115) | 1.80791357 |
| 154 | Thin bony cortex (HP:0002753) | 1.79027272 |
| 155 | High pitched voice (HP:0001620) | 1.78885116 |
| 156 | Gastrointestinal inflammation (HP:0004386) | 1.78355653 |
| 157 | Emphysema (HP:0002097) | 1.77462412 |
| 158 | Lip pit (HP:0100267) | 1.77091543 |
| 159 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75672415 |
| 160 | Long eyelashes (HP:0000527) | 1.75485870 |
| 161 | Long toe (HP:0010511) | 1.71265919 |
| 162 | Hyporeflexia of lower limbs (HP:0002600) | 1.70633740 |
| 163 | Deep venous thrombosis (HP:0002625) | 1.69777484 |
| 164 | Cafe-au-lait spot (HP:0000957) | 1.66654094 |
| 165 | Distal lower limb muscle weakness (HP:0009053) | 1.65677540 |
| 166 | Slow saccadic eye movements (HP:0000514) | 1.65265472 |
| 167 | Cystic hygroma (HP:0000476) | 1.60702132 |
| 168 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.59951388 |
| 169 | Abnormal foot bone ossification (HP:0010675) | 1.56343385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.88590104 |
| 2 | SCYL2 | 4.57868255 |
| 3 | PIK3CA | 3.67462066 |
| 4 | CDK12 | 3.57874923 |
| 5 | MAP4K1 | 3.48725229 |
| 6 | PKN2 | 3.33043453 |
| 7 | SIK1 | 3.25570089 |
| 8 | MAP3K14 | 2.88156963 |
| 9 | NEK6 | 2.71517742 |
| 10 | SMG1 | 2.59645668 |
| 11 | JAK3 | 2.46993955 |
| 12 | SIK3 | 2.42674126 |
| 13 | TYK2 | 2.41936254 |
| 14 | TXK | 2.40124032 |
| 15 | STK10 | 2.24827309 |
| 16 | MAPKAPK3 | 2.07807744 |
| 17 | IRAK3 | 2.01730468 |
| 18 | PIM1 | 1.94371426 |
| 19 | IRAK4 | 1.86307095 |
| 20 | KIT | 1.72322654 |
| 21 | NEK2 | 1.71431536 |
| 22 | * IKBKB | 1.70762953 |
| 23 | STK4 | 1.63151060 |
| 24 | ZAP70 | 1.59952505 |
| 25 | ZAK | 1.59493977 |
| 26 | BRD4 | 1.57475339 |
| 27 | IKBKE | 1.55596691 |
| 28 | MKNK2 | 1.54858326 |
| 29 | CSF1R | 1.53101880 |
| 30 | WEE1 | 1.52251179 |
| 31 | AKT3 | 1.50077544 |
| 32 | SRPK1 | 1.49088678 |
| 33 | CDC7 | 1.47352523 |
| 34 | TGFBR2 | 1.47282469 |
| 35 | JAK1 | 1.46827082 |
| 36 | BLK | 1.45011486 |
| 37 | MAP3K12 | 1.43215426 |
| 38 | MAP2K2 | 1.39382367 |
| 39 | * CHUK | 1.34951615 |
| 40 | TTK | 1.34706751 |
| 41 | TSSK6 | 1.33584649 |
| 42 | MKNK1 | 1.33406399 |
| 43 | CLK1 | 1.32859479 |
| 44 | ERN1 | 1.27692042 |
| 45 | BUB1 | 1.25556303 |
| 46 | STK3 | 1.25024326 |
| 47 | EPHA2 | 1.22815783 |
| 48 | CDK4 | 1.22404213 |
| 49 | RPS6KB1 | 1.20644373 |
| 50 | FGFR3 | 1.14841172 |
| 51 | LATS1 | 1.14026705 |
| 52 | BMPR2 | 1.13322225 |
| 53 | MARK3 | 1.12334418 |
| 54 | CSK | 1.10832023 |
| 55 | TEC | 1.10032120 |
| 56 | ATR | 1.09539830 |
| 57 | ICK | 1.07115394 |
| 58 | PLK4 | 1.06693441 |
| 59 | EIF2AK3 | 1.06206626 |
| 60 | TBK1 | 1.06080132 |
| 61 | BTK | 1.05792582 |
| 62 | LCK | 1.04075470 |
| 63 | MUSK | 1.02765984 |
| 64 | HCK | 1.02667540 |
| 65 | NLK | 0.98755106 |
| 66 | PLK1 | 0.98070896 |
| 67 | SYK | 0.97745347 |
| 68 | STK38L | 0.96457122 |
| 69 | RPS6KA4 | 0.96126440 |
| 70 | NEK9 | 0.96011160 |
| 71 | TAF1 | 0.94489720 |
| 72 | PDPK1 | 0.92729233 |
| 73 | PDK1 | 0.92695353 |
| 74 | CAMK1D | 0.90631676 |
| 75 | CDK7 | 0.90621734 |
| 76 | CHEK2 | 0.90320776 |
| 77 | MAP3K9 | 0.89523600 |
| 78 | STK24 | 0.89013719 |
| 79 | FGFR4 | 0.86926451 |
| 80 | RET | 0.86149432 |
| 81 | EEF2K | 0.85968806 |
| 82 | CDK6 | 0.85278586 |
| 83 | MAP2K1 | 0.84617728 |
| 84 | EIF2AK2 | 0.84265746 |
| 85 | MAP2K3 | 0.83328053 |
| 86 | ITK | 0.82404081 |
| 87 | YES1 | 0.79499446 |
| 88 | BRSK2 | 0.78545706 |
| 89 | MAP3K8 | 0.78433277 |
| 90 | MAP3K2 | 0.76484244 |
| 91 | CHEK1 | 0.75869181 |
| 92 | LRRK2 | 0.75171699 |
| 93 | PLK3 | 0.74479949 |
| 94 | PTK6 | 0.74270836 |
| 95 | AURKB | 0.73756753 |
| 96 | FLT3 | 0.72249759 |
| 97 | PRPF4B | 0.71354855 |
| 98 | MELK | 0.71154056 |
| 99 | MAPK11 | 0.70722644 |
| 100 | EPHB1 | 0.70138805 |
| 101 | TAOK3 | 0.70002180 |
| 102 | JAK2 | 0.69546312 |
| 103 | EIF2AK1 | 0.69531431 |
| 104 | TRIM28 | 0.69435844 |
| 105 | MAPKAPK2 | 0.69298449 |
| 106 | LYN | 0.68767762 |
| 107 | ALK | 0.68647089 |
| 108 | RIPK4 | 0.68629267 |
| 109 | PRKCI | 0.68451186 |
| 110 | MAP3K13 | 0.67346428 |
| 111 | ATM | 0.66569353 |
| 112 | FGFR2 | 0.66132871 |
| 113 | NUAK1 | 0.65230510 |
| 114 | TTN | 0.64707286 |
| 115 | KSR1 | 0.64108575 |
| 116 | ACVR1B | 0.63819916 |
| 117 | RPS6KA2 | 0.62380527 |
| 118 | VRK1 | 0.60884019 |
| 119 | TRPM7 | 0.60479842 |
| 120 | RPS6KB2 | 0.60333368 |
| 121 | SGK3 | 0.60006518 |
| 122 | RPS6KA5 | 0.58466828 |
| 123 | GRK6 | 0.58354694 |
| 124 | SGK2 | 0.58016135 |
| 125 | TLK1 | 0.57516740 |
| 126 | CDK9 | 0.57201607 |
| 127 | IRAK2 | 0.56149489 |
| 128 | PDGFRA | 0.54285658 |
| 129 | CDK2 | 0.54024924 |
| 130 | ILK | 0.51187599 |
| 131 | MAP3K3 | 0.50025804 |
| 132 | KSR2 | 0.49925468 |
| 133 | NME2 | 0.49721371 |
| 134 | PAK4 | 0.47102723 |
| 135 | PIM2 | 0.46921123 |
| 136 | MTOR | 0.44387411 |
| 137 | HIPK2 | 0.41941385 |
| 138 | * ABL1 | 0.41055651 |
| 139 | MAP3K10 | 0.40566373 |
| 140 | PASK | 0.37777598 |
| 141 | MST4 | 0.37048133 |
| 142 | TESK2 | 0.33638400 |
| 143 | RPS6KC1 | 0.30009638 |
| 144 | RPS6KL1 | 0.30009638 |
| 145 | MAP3K1 | 0.29263538 |
| 146 | PRKD1 | 0.28008982 |
| 147 | PBK | 0.25120860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36569544 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.34651004 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.29514636 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.28647337 |
| 5 | Endometrial cancer_Homo sapiens_hsa05213 | 2.27658161 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.22521743 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04482143 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.95413097 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 1.86772891 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85985164 |
| 11 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.85967053 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.85250557 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.83466410 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76193167 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75954827 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75337479 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73742347 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73358757 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.73194426 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.65483432 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.62453064 |
| 22 | RNA transport_Homo sapiens_hsa03013 | 1.62392607 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60222130 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.59167205 |
| 25 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.59083853 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.49404062 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46948312 |
| 28 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.46802586 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.46106479 |
| 30 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.44753103 |
| 31 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.44631509 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.43873023 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.43688831 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43283343 |
| 35 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.42979418 |
| 36 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.40915717 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40843724 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39810002 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36753081 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36133181 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34364920 |
| 42 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.33604231 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.32292510 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.31853153 |
| 45 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.31179404 |
| 46 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.30793312 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.30128417 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29646426 |
| 49 | Insulin resistance_Homo sapiens_hsa04931 | 1.29207523 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23441309 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21280527 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 1.19404292 |
| 53 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16299216 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.15882378 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.15641599 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 1.14767043 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14248049 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13259553 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.11142862 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 1.10641073 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10162847 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08325691 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08047607 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 1.06897582 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 1.05786944 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04402281 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03474380 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03461660 |
| 69 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02258816 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02083366 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01759812 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01119532 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99466943 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.99129509 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98583273 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97023962 |
| 77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95603715 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.95397553 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90521413 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88710408 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.86868737 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.83300097 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83001245 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.82826952 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.82624088 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80607831 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80468038 |
| 88 | Melanoma_Homo sapiens_hsa05218 | 0.79384413 |
| 89 | Malaria_Homo sapiens_hsa05144 | 0.79081255 |
| 90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78488768 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76465480 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.73918036 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.73647457 |
| 94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71758347 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.71008724 |
| 96 | Adherens junction_Homo sapiens_hsa04520 | 0.70236130 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68304605 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68241591 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.65088382 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64798951 |
| 101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63498939 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62988496 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.62512301 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61252018 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.60518578 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59532610 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58790298 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58447370 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58276194 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58271067 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.58185454 |
| 112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57275360 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.56765098 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56247764 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55438604 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54180125 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53637586 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52017482 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51203010 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51135401 |
| 121 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49694951 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48621577 |
| 123 | Platelet activation_Homo sapiens_hsa04611 | 0.48487941 |
| 124 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48034808 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46396601 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45341179 |
| 127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44810076 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44487950 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44477624 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43205437 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42016559 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39842291 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38472089 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38261527 |

